Week of March 29th, 2021 | Vol. 10, Issue 14
In This Issue
Featured Headlines
Recent Industry Transactions
Industry Trading Comps
Recent Industry Headlines
Market Reports
Upcoming Events

Quick Links

Contact Information
Managing Director
Business Development

Managing Director
Head of M&A and Capital Advisory

Above is an overview of recent industry M&A activity. For additional information, see the charts below or click on the chart above to download complete transaction tables broken out by industry sub sectors.

For more information about our consumer healthcare JV with The Emerson Group, Daybreak Consumer Care, click here.
Recent Materials Providing Insight Into Healthcare Related Industries
Current M&A Pipeline
Representative Current Retained Sell-Side And Partnering Opportunities
Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics

Project Aspen
Sell-side | CDMO | Multinational CDMO headquartered in US

Project Athena
Sell-side / Licensing | Medical Device | Novel device for pelvic organ prolapse

Project Bulldog
Sell-side | Pharma Services| Life sciences consulting firm
Lonza completed the divestment of its Ploermel, France and Edinburgh, UK sites to NextPharma, exiting both softgels and liquid-filled hard capsules for the pharma market but retaining capability for feasibility studies as part of a technology selection offering.

The Ploermel and Edinburgh sites employ around 260 and 130 permanent staff respectively. They produce liquid-filled hard capsules, including Licaps, and softgels for high potent and hormonal products.

An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
Pharma & Biotech
14 transactions totaling $1,682 million
Supplies, Equipment & Services
23 transactions totaling $1,341 million
Healthcare IT & Managed Care
6 transactions totaling $26 million
Healthcare Facilities & Distributors
12 transactions totaling $205 million
Pharma & Biotech
37 transactions totaling $875 million
Supplies, Equipment & Services
24 transactions totaling $1,049 million
Healthcare IT & Managed Care
16 transactions totaling $306 million
Healthcare Facilities & Distributors
5 transactions totaling $32 million
Pharma & Biotech
25 transactions totaling $1,625 million
Supplies, Equipment & Services
5 transactions totaling $222 million
Healthcare IT & Managed Care
1 transaction totaling $33 million
Healthcare Facilities & Distributors
3 transactions totaling $214 million
A Breakdown of Relevant Trading Multiples
Each week, we provide updated trading comps for leading companies from numerous healthcare sub-sectors.
To the right you will see a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
A Sampling of Relevant Industry Headlines from Last Week
Below are snippets from relevant industry news articles from the past week. For additional information or the article's complete text, click the headline link to view the original publication.
April 2, 2021 - Contract Pharma
NIAID Director Dr. Anthony Fauci said the United States may not need the AstraZeneca COVID-19 vaccine because contracts with other suppliers are sufficient to vaccinate the entire population and perhaps provide booster shots in the fall.

April 2, 2021 - Fierce Biotech
SomaLogic is a unicorn among unicorns: Not only did the company, which builds AI-powered technology for protein analysis, wait to close its series A funding round until it had more than two decades of experience under its belt, but it has quickly followed up its $214 million fundraising late last year with new plans to go public.

April 1, 2021 - Contract Pharma
Servier, a global pharmaceutical company, has successfully completed its acquisition of Agios Pharmaceuticals' commercial, clinical and research-stage oncology portfolio for up to $2 billion plus royalties. The acquisition strengthens Servier's commercial presence in the U.S. malignant hematology market and provides the potential for long-term growth into the solid tumor space.

April 1, 2021 - Fierce Healthcare
The ID verification service gives patients a simpler and more secure way to prove their identity online and in person when accessing healthcare services. Rather than relying on username and password credentials, the service employs a password-less authentication process through the use of smart biometrics, the companies said in a press release.
Welcome to Bourne, let's talk.

Since our founding in 2001, Bourne Partners has remained focused on fulfilling the unique needs of established, middle-market healthcare and pharmaceutical companies across the globe. Our track record includes advising middle market companies in healthcare M&A assignments totaling more than $7 billion, and growing companies into successful and well-positioned pharmaceutical enterprises.